Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Legislation
    • Boards and Committees
    • Quality Management System
    • Contact Us
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Report a Problem
Home > Safety Info > Product Recalls > Recall Alerts > Drug Product Recall: Cefim 100mg/5ml Suspension (Batch#134774) , M/S Hilton Pharma (Pvt.) Ltd., Karachi

Drug Product Recall: Cefim 100mg/5ml Suspension (Batch#134774) , M/S Hilton Pharma (Pvt.) Ltd., Karachi

Asad Ullah Recall Alerts February 22, 2022February 22, 2022

CDL Karachi has declared the batch No. 134774 of product “Cefim Suspension” as substandard and spurious.

Cefim-Suspension-Recall-Alert-05

Share this:

  • Twitter
  • Facebook
  • ← CEO, DRAP will hold Khuli E-Kachehri on 28th February, 2022
  • Drug Product Recall: Cefim DS 200mg/5ml Suspension (Batch#141865) by M/S Hilton Pharma (Pvt.) Ltd., Karachi →
  • Product Recalls
    • Recall Alerts
    • Therapeutic Products Recalls
    • Recalls and Rapid Alerts
  • Safety Communication
    • Safety Alerts
    • Health Professional Alerts
  • Safety Reporting
    • How DRAP Monitor Safety
    • How to Report Adverse Events?
    • Pharmacovigilance System
  • Report a Problem
    • Reporting Adverse Events
    • Product Quality Defects
    • COVID-19 Vaccine

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem